Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
SAB298
i
Other names:
SAB298
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Sabila Biosci
Drug class:
SRC-family kinase (SFK) inhibitor
Related drugs:
‹
CCT241161 (2)
SU6656 (2)
CCT196969 (1)
CCT241161 (2)
SU6656 (2)
CCT196969 (1)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
NRAS mutation
Melanoma
NRAS mutation
Melanoma
SAB298
Sensitive: D – Preclinical
SAB298
Sensitive
:
D
SAB298
Sensitive: D – Preclinical
SAB298
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.